How India grew to become the pharmacy of the world

[ad_1] The telephone rang simply earlier than midnight.

It was early February in 2001 in Mumbai, and Yusuf Hamied, a seasoned chemist on the Indian multinational pharma firm Cipla, was at a cocktail party. He picked up the telephone anyway. A New York Instances reporter was on the road, calling to verify a rumor: Was Hamied actually providing HIV meds for $1 a day?

This story is a part of the 2025 Future Excellent 25

Yearly, the Future Excellent crew curates the undersung activists, organizers, and thinkers who're making the world a greater place. This 12 months’s honorees are all holding progress on world well being and growth alive. Read more about the project here .

In 2001, AIDS — which develops when HIV goes untreated — killed around 3 million individuals, 70 % of whom had been in Africa. The primary therapy, antiretroviral remedy, was remarkably efficient however out of attain for a lot of the world, working about $10,000 to $15,000 a 12 months per affected person. Tens of millions of individuals had been dying as a result of they couldn’t afford these costs.

The Instances reporter’s rumor turned out to be true. Hamied’s firm Cipla had simply publicly provided the most recent HIV therapy to the help group Doctors Without Borders for less than $350 a 12 months — a 97 % worth minimize over prevailing medicine. Virtually in a single day, a remedy as soon as priced for wealthy nations was all of the sudden inside attain for the nations hit hardest by AIDS.

“Dr. Hamied, your life won't be the identical from tomorrow,” the reporter said , and hung up.

The subsequent morning, the story of Hamied’s accomplishment was on the front page of the Times . The information ricocheted via assist businesses, well being ministries, and the halls of Washington. The Cipla provide “adjustments every little thing,” Toby Kaspar, an official of Docs With out Borders, said at the time .

Indian generics would quickly turn into the spine of the worldwide HIV response. Inside two years, the US launched PEPFAR, the President’s Emergency Plan for AIDS Relief , a large $15 billion program to ship HIV therapy to sub-Saharan Africa and past. Within the final 20 years, that single program has helped save more than 25 million lives.

That victory was solely potential at that scale due to low-cost Indian generic medicine, which helped PEPFAR save almost $1 billion early on, in accordance with a US Government Accountability Office report . The competitors created by these generics additionally drove the price of HIV medicine additional down.

That dollar-a-day provide in 2001 felt like a miracle, but it surely wasn’t. It was the payoff of a pharma revolution that had been quietly constructing for many years. India didn’t simply stumble into turning into the world’s pharmacy. It obtained there via a sequence of intentional and defiant decisions.

<img alt="" data-chromatic="ignore" loading="lazy" decoding="async" data-nimg="fill" class="mvmjsc0" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' %3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3CfeColorMatrix values='1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 100 -1' result='s'/%3E%3CfeFlood x='0' y='0' width='100%25' height='100%25'/%3E%3CfeComposite operator='out' in='s'/%3E%3CfeComposite in2='SourceGraphic'/%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage width='100%25' height='100%25' x='0' y='0' preserveAspectRatio='none' style='filter: url(%23b);' href='data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mN8+R8AAtcB6oaHtZcAAAAASUVORK5CYII='/%3E%3C/svg%3E")" sizes="(max-width: 639px) 100vw, (max-width: 1023px) 50vw, 700px" srcset="https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=256 256w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=376 376w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=384 384w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=415 415w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=480 480w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=540 540w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=640 640w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=750 750w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=828 828w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=1080 1080w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=1200 1200w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=1440 1440w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=1920 1920w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=2048 2048w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=2400 2400w" src="https://platform.vox.com/wp-content/uploads/sites/2/2025/11/7AolV-span-style-font-size-24px-indian-generics-helped-slash-hiv-deaths-worldwide-span-_3662fa.png?quality=90&strip=all&crop=0%2C0%2C100%2C100&w=2400"/> View the interactive version here

Right now, Indian generics dominate the world. By one estimate , roughly 60 % of prescription tablets and capsules for the US market at the moment are made in India. Throughout Africa and plenty of Asian nations, the share is even greater. Main assist businesses like UNICEF and International Fund supply most of their HIV medicine and different necessities from Indian drugmakers. And generic competitors has pushed the popular HIV therapy in poor nations to under $45 a year .

However India’s dominance got here at a price.

Lately, contaminated cough syrups from India have been linked to the deaths of greater than 140 children abroad. And dependence on the nation’s producers has turn into so nice that when a single Indian manufacturing facility making a vital most cancers drug shut down in 2023, US hospitals were forced to ration chemotherapy , even turning to China for emergency imports.

For many years, there was an implicit cut price made with India. In trade for a flood of reasonably priced, lifesaving medicines — the identical generics that turned HIV from a loss of life sentence right into a treatable illness — the world would tolerate a system constructed for the bottom potential worth. Now, that cut price is breaking, and the pharmacy of the world is turning into a choke level.

And that is all unfolding simply because the world is about to lean even more durable on India. Demand for drugs that deal with persistent situations akin to diabetes and coronary heart illness is climbing. Patents on weight-loss blockbusters like Ozempic will begin to expire over the following decade, opening a market that analysts say could reach around $100 billion a year , which might ship much more quantity to the most cost effective, highest-capacity makers.

The query isn’t whether or not India could make the world’s medicine. It’s whether or not it will possibly make them safely and reliably — and whether or not it will possibly adapt to the wants of the long run.

How India grew to become the pharmacy of the world

India gained independence from the UK in 1947, however its patent system remained caught within the colonial period. Below outdated British guidelines, if a Western firm invented a drug, it successfully owned the drug itself — the elemental molecule — and nobody else might make it.

India’s personal governmental reviews warned that these guidelines had been choking off native manufacturing, but they remained in place for many years. Consequently, the nation needed to rely closely on Western drugmakers for nearly each important medication.

By 1966, newly elected Prime Minister Indira Gandhi noticed a chance to vary that. Her socialist authorities was building momentum , nationalizing banks and pushing a robust marketing campaign for “self-reliance.” India was creating its personal public-sector drug firms. However patent hurdles stood in the way in which of innovation and self-sufficiency.

So in 1970, India rewrote the foundations. The new Patents Act made a surprisingly easy however transformative change: it eradicated product patents for medicine and meals, permitting solely course of patents. An organization might not personal a drug outright — solely its specific approach of constructing it. If an Indian agency like Cipla might determine a distinct solution to make the identical drug, it might legally promote it.

That meant that if an Indian drug firm modified the manufacturing steps even barely, it might declare a brand new course of and legally promote the identical drug. As Achal Prabhala, a public well being activist who campaigns for access to medicines , places it, “having no product patents was equal to having no patents.”

<img alt="Lab technicians in white coats test medicines at a Cipla quality-control laboratory in Mumbai." data-chromatic="ignore" loading="lazy" decoding="async" data-nimg="fill" class="mvmjsc0" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' %3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3CfeColorMatrix values='1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 100 -1' result='s'/%3E%3CfeFlood x='0' y='0' width='100%25' height='100%25'/%3E%3CfeComposite operator='out' in='s'/%3E%3CfeComposite in2='SourceGraphic'/%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage width='100%25' height='100%25' x='0' y='0' preserveAspectRatio='none' style='filter: url(%23b);' href='data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mN8+R8AAtcB6oaHtZcAAAAASUVORK5CYII='/%3E%3C/svg%3E")" sizes="(max-width: 639px) 100vw, (max-width: 1023px) 50vw, 700px" srcset="https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=256 256w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=376 376w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=384 384w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=415 415w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=480 480w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=540 540w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=640 640w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=750 750w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=828 828w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=1080 1080w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=1200 1200w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=1440 1440w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=1920 1920w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=2048 2048w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=2400 2400w" src="https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-823904.jpg?quality=90&strip=all&crop=0%2C4.5833333333333%2C100%2C90.833333333333&w=2400"/> Scientists at Cipla’s quality-control lab in Mumbai in 2001. Round this time, Indian companies had been perfecting low-cost variations of Western medicines, together with the $1-a-day HIV cocktail that shook the worldwide drug market. Alyssa Banta/Newsmakers by way of Getty Photos

A brand new wave of companies, together with Cipla, turned reverse-engineering right into a craft after which an trade. India’s generics trade blossomed, although outdoors the nation, nearly no person was paying consideration. In greenback phrases, the nation was principally a rounding error within the world medicine market.

However then coverage choices made removed from New Delhi supercharged India’s generic trade.

In 1984, the USA handed the Hatch-Waxman Act , which primarily created a quick lane for generic drug candidates. As a substitute of repeating years-long, wildly costly medical trials, generic makers might win approval by displaying their model behaved the identical approach within the physique because the brand-name drug. Instantly, it grew to become a lot simpler and cheaper for generic medicine to enter the US market.

The second vital transfer got here from Geneva. In 2001, The World Well being Group launched its medicines prequalification program to vet medicine for UN businesses and large funders. Indian producers rapidly met this system’s high quality requirements and, inside just a few years, made up a big share of HIV, TB, and malaria medicines on its authorized lists.

By the early 2000s, Indian drug makers had turn into main exporters of low-cost generics to different creating nations and had been beginning to carve out a foothold within the US market.

India’s battle to maintain its quirky patent system

Western pharmaceutical firms, media conglomerates, and tech giants noticed India’s patent mannequin as a direct menace. Starting within the late Seventies, a small group of executives from Pfizer, IBM, and different US giants — together with Warner Communications — lobbied Washington to rewrite the worldwide commerce guidelines on mental property. They pushed to shift the locus of enforcement out of a sleepy forum with almost no real power into the brand new World Commerce Group (WTO), the place breaking the foundations might set off commerce sanctions. And it labored.

The outcome was TRIPS — Trade-Related Aspects of Intellectual Property Rights — a world treaty that inextricably tied patents with commerce, and primarily required member nations to simply accept the entire package deal of guidelines, together with the patent ones. In apply, it was an all-or-nothing selection: be a part of the system that governs almost all world commerce on TRIPS phrases, or stand outdoors it. Critics accused wealthy nations like the USA and Japan of “ pulling up the ladder ” as a result of they themselves had constructed key industries by copying international know-how, solely to now shut that path off for everybody else.

Earlier than I grew to become a journalist, I labored inside India’s pharmaceutical trade. Again then, I considered the nation as “the place that made lifesaving medicine obtainable for individuals who’d by no means afford them in any other case,” and I used to be pleased with that. It felt like one of many uncommon methods India was clearly making the world higher off.

However reporting this piece has pressured me to revisit that feeling. It was fascinating to dig into the early ethical arguments and the political maneuvering that made India’s “pharmacy of the world” potential within the first place. However the extra I learn, and the extra I talked to individuals who’d investigated the trade, the clearer it grew to become that India’s dominance over the event of generic medicine had a darkish facet.

Most of us have in all probability swallowed Indian-made tablets with out ever enthusiastic about it, and I wished to grasp how they’re made, how the system we’ve relied on is beginning to fail us, and what India’s function is in holding — or shedding — the world’s entry to medication.

India begrudgingly accepted the discount, selecting to take successful to its pharmaceutical sector to be able to preserve promoting textiles and farm items overseas and achieve entry to richer markets. As soon as India signed on, the WTO gave it a decade of grace interval — till 2005 — to dismantle its outdated patent regulation and restore product patents.

However for India, it was, in Prabhala’s phrases, “shedding a pawn to achieve a knight.”

Because the deadline approached, lawmakers started drafting a brand new patent regulation. Then, a political earthquake hit. India’s BJP-led ruling alliance occasion was unexpectedly voted out in 2004. The brand new authorities, led by the Congress occasion, relied on the assist of a small bloc of communist events that had spent a long time railing towards monopolies. “We advised the federal government that we are able to assist the laws provided that you settle for our solutions in nationwide curiosity,” one communist leader said at the time .

The brand new authorities hammered out an improvised compromise: it might restore product patents as TRIPS required, however attempt to curb drug monopolies. In March 2005, with nearly no debate, the federal government slipped in a last-minute change that set a better bar than the US or Europe for what counted as significant innovation.

“Right here’s the ground TRIPS units — what if we dig it 5 ft deeper?” mentioned Prabhala, who campaigned alongside activists for India’s 2005 patent regulation. “It’s nonetheless the ground, proper?”

The brand new clause aimed squarely at one among pharma’s favourite methods: evergreening, which is when firms stretch a monopoly by making minor tweaks to an outdated drug — a brand new coating, a distinct salt, a slow-release model. Below the brand new rule, you couldn’t get a recent patent only for repackaging an outdated medication. You needed to present the brand new model really labored higher for sufferers.

The worldwide pharma trade instantly fired again.

The primary massive take a look at got here in 2006 from Novartis, the Swiss drug maker behind the most cancers drug Glivec. It wished a brand new Indian patent not on the unique molecule, however on a brand new type of the identical drug. India’s patent workplace rejected it, citing the brand new regulation.

Novartis, in response, went to a state excessive courtroom in southern India to dismantle the regulation itself, arguing that the Indian clause was unconstitutional and violated WTO guidelines. A win for Novartis would make it simpler for minor patent tweaks to outdated medicine to delay generics — an actual danger not solely to Indian firms, however to the thousands and thousands of people that relied on Indian-made medicine.

<img alt="HIV-rights activists stand in front of a tall Novartis office building in Mumbai, holding signs that read “No patents on AIDS drugs” and “Drop the case,” during a street protest." data-chromatic="ignore" loading="lazy" decoding="async" data-nimg="fill" class="mvmjsc0" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' %3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3CfeColorMatrix values='1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 100 -1' result='s'/%3E%3CfeFlood x='0' y='0' width='100%25' height='100%25'/%3E%3CfeComposite operator='out' in='s'/%3E%3CfeComposite in2='SourceGraphic'/%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage width='100%25' height='100%25' x='0' y='0' preserveAspectRatio='none' style='filter: url(%23b);' href='data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mN8+R8AAtcB6oaHtZcAAAAASUVORK5CYII='/%3E%3C/svg%3E")" sizes="(max-width: 639px) 100vw, (max-width: 1023px) 50vw, 700px" srcset="https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=256 256w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=376 376w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=384 384w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=415 415w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=480 480w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=540 540w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=640 640w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=750 750w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=828 828w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=1080 1080w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=1200 1200w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=1440 1440w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=1920 1920w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=2048 2048w, https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=2400 2400w" src="https://platform.vox.com/wp-content/uploads/sites/2/2025/11/gettyimages-684219872.jpg?quality=90&strip=all&crop=0%2C2.6731752673175%2C100%2C94.653649465365&w=2400"/> Activists protest outdoors Novartis’s Mumbai places of work in 2011, opposing the corporate’s courtroom problem to India’s patent regulation and warning it might threaten reasonably priced generic medicines. Kalpak Pathak/Hindustan Instances by way of Getty Photos

Then got here a twist. Earlier than a pivotal 2007 listening to, a authorities knowledgeable panel launched a report hinting that India’s more durable patent guidelines would possibly conflict with TRIPS. For Novartis, it appeared like helpful ammunition, till activists combed via the textual content and observed acquainted language. Passages appeared to be lifted nearly verbatim from a examine funded by a pharma trade group that included Novartis.

The report was withdrawn, and Novartis misplaced its finest speaking level. The excessive courtroom rejected the corporate’s problem, and in 2013, India’s Supreme Court docket put an end to the case . India’s new regulation stood; Novartis’ patent didn't.

David had crushed Goliath in courtroom. However might he preserve successful within the factories that now equipped the world?

India bent the foundations with out breaking them, and the world obtained low-cost medicine due to it. However that cut price rested on an unwritten promise: that generic medicines can be low-cost, sure, however that they’d additionally work. Right now, that basis is cracking.

For years, reporters and whistleblowers flagged Indian-made medicines in poorer nations as substandard or contaminated, however outdoors public-health circles, these warnings barely registered. When outsiders have raised the alarm, the federal government’s intuition has usually been to suppress. When lecturers revealed research discovering substandard Indian medicine in Africa in 2014, for instance, the federal government threatened to sue the researchers reasonably than act on their findings.

In 2022, two deadly outbreaks confirmed how contaminated medicine can slip via India’s safeguards. Within the Gambia, pediatric acute kidney an infection instances had been tied to 4 Indian-made cough syrups; the WHO issued a world alert after labs discovered diethylene and ethylene glycol within the merchandise, leading to the deaths of 141 children . A couple of months later, Uzbekistan reported baby deaths linked to syrups from one other Indian agency; a courtroom later convicted 23 people over the episode . That very same 12 months, the WHO issued a global alert highlighting how shaky India’s drug oversight may be.

Based on Dinesh Thakur, a public well being activist and pharma whistleblower , and Prabhala, India’s drug trade covertly operates a two-track system : one set of factories constructed to impress international inspectors, and one other for India and poorer markets. States gather licensing charges from producers, in order that they have little urge for food for shutting vegetation down. Even when unhealthy actors are caught, the penalties are largely administrative — a 60-day suspension after which again to enterprise. Consequently, many producers do exactly sufficient to scrape via inspections.

After the Gambia scandals, regulators ran nationwide inspections and advised producers to improve vegetation to WHO-level requirements or shut them down. Some licenses have been cancelled, and some house owners arrested. However even the WHO says India nonetheless has “an extended solution to go,” stating that exports now face more durable checks than many medicine offered at residence.

The response has thus far been “piecemeal reforms, opaque and badly worded laws, and the absence of each sources and the need to implement high quality requirements,” Thakur mentioned. India nonetheless has no actual nationwide system for recalling unhealthy medicine as soon as they’ve gone out the door.

However even when India reforms its pharmaceutical system, extra challenges are on the way in which.

The world’s disease map is changing . Local weather change and new pandemics will demand vaccines and therapies that don’t exist but. As extra nations get richer and older, persistent situations will likely be answerable for extra deaths. And India has been largely lacking from the worldwide race to create new first-in-class medicines.

India’s generic increase was constructed on old-school chemistry: “small-molecule” tablets. Assume statins for ldl cholesterol, HIV medicine, blood strain tablets — medicines that, as soon as you already know the method, a talented chemist can copy and switch into an inexpensive capsule. That’s the world India mastered. However the brand new frontier isn’t like that. It runs from weight-loss injections like Ozempic and Wegovy to cancer-treating antibodies and experimental gene and cell therapies — complicated biologic medicine grown from dwelling cells, not simply chemical substances blended and pressed right into a pill.

It’s considerably more difficult to reverse-engineer these the way in which you'll for a ldl cholesterol capsule. China has managed it, making biotech an specific nationwide precedence and pouring public cash into labs, analysis parks, and startups. Right now, Chinese language companies account for roughly 30 percent of the drug molecules that Huge Pharma is now licensing from outdoors firms, together with new most cancers and autoimmune therapies.

A handful of Indian companies are making cheaper variations of insulin and most cancers antibodies or signing licensing offers, however a majority of the trade continues to be geared to make low-cost generics as soon as a patent lifts. And India nearly by no means invents the underlying medicine.

If the following breakthroughs are invented in Boston and Beijing, and India isn’t in that room, poorer nations could by no means see an inexpensive model in any respect. That’s as a result of there’s nothing Indian factories can legally copy till another person has completed the exhausting, costly science first.

Huge Western drug makers usually spend round 20 % of their gross sales on analysis and growth, while Indian pharma companies are closer to 7 percent . India as an entire places little over half a % of its GDP into R&D, whereas China allocates more than four times that share . In 2024, Cosentyx, a drug from Novartis that treats psoriasis and arthritis, brought in more revenue than Sun Pharma , India’s greatest drug firm, made throughout its complete world enterprise.

Until India finds a approach, its “pharmacy of the world” mannequin dangers turning into a pharmacy of yesterday’s medicine, with the latest medicines reserved for individuals who will pay full worth. On paper, India nonetheless has one of the crucial radical patent legal guidelines on the planet — and it nonetheless has the potential to do the world a whole lot of good.

If India can repair its high quality disaster and begin investing in new science, the regulation it fought for might as soon as once more be used to push down costs on the following technology of medicine, the way in which it as soon as did for HIV therapy. If it doesn’t, that hard-won regulation will keep principally symbolic — and India will likely be remembered extra for what it might have completed for world well being than for what it selected to do.

You’ve learn 1 article within the final month

Right here at Vox, we're unwavering in our dedication to masking the problems that matter most to you — threats to democracy, immigration, reproductive rights, the surroundings, and the rising polarization throughout this nation.

Our mission is to offer clear, accessible journalism that empowers you to remain knowledgeable and engaged in shaping our world. By turning into a Vox Member, you immediately strengthen our capability to ship in-depth, unbiased reporting that drives significant change.